Discussion Our systematic review demonstrates that GLP-1 receptor agonists (GLP-1 RAs), including semaglutide, liraglutide, tirzepatide, and exenatide, offer sustained efficacy in weight management, with consistent improvements in glycemic control among patients with obesity or overweight
All publications available within PubMed, Google Scholar, and Cochrane databases were reviewed for peer-reviewed journal articles, clinical trial data, and evidence-based reviews
Sheahan et al
The brand's materials indicate the B-complex plays a supporting role rather than a primary one in the formula
NuraPatch requires no prescription or medical evaluation
I have not had any patients who reported being duped by influencers